期刊文献+

急性中度等容血液稀释对维库溴铵药代动力学的影响 被引量:2

Effect of Acute Moderate Isovolumic Hemodilution on the Pharmacokinetics of Vecuronium
下载PDF
导出
摘要 研究观察了急性中度等容血液稀释对维库澳馁药代动力学的影响。26例ASAI级施择期整形外科手术的患者,平均分成对照组和血液稀释组。静注维库澳铵100μg/kg后,用荧光法测定血药浓度。并用3P87药代动力学程序进行计算。维库溴铵的体内过程能用三室开放模型完整描述。与对照组相比,血液稀释组患者的中央室分布容积(Vc)和稳态分布容积(Vdss)明显增大,排泄半衰期(T1/2β)明显延长,而快分布相半衰期(T1/2π)、分布半衰期(T1/2α)、药物转运速车常数(K12、K21、K13、K31、K10)、曲线下面积(AUC)、平均残留时间(MRT)和血浆清除率(Cl)在两组间差别不明显。 To determine the effect of acute moderate isovolemic hemodi1ution on pharmacokinetics of vecuronium. Methods Twenty-six adult patients,ASA grade I, undergoing elective plastic surgery, were randomly divided equally into the control and hemodilution group. The blood samples were taken for 5 hours following intravenous bolus of 100μg/kg of vecuronium in two groups. The plasma concentrations of vecuronium were determined with an improved fluorometry and the pharmacokinetic parameters were obtained by fitting the data with a 3P87program. Results The disposition of vecuronium can be best described by a three compartment open model. As comparison with the control group,the values of Vc and Vdss ln hemodilution group were greater than that in the control,while T1/2β was markedly prolonged in this group. There were no significant differences in T1/2π, T1/2α, K12, K21, K13, K31, K10, MRT, AUC, and Cl between the two groups. Conclusion Acute moderate isovolemic hemodilution could change the pharmacokinetics of vecurinium,particularly in distribution and elimination phases.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 1997年第6期456-460,共5页 Acta Academiae Medicinae Sinicae
基金 中国医学科学院中国协和医科大学政策性基金!9540O6
关键词 急性血液稀释 维库溴铵 药代动力学 acute moderate isovolemic hemodilution vecuronium pharmacokinetics
  • 相关文献

参考文献1

二级参考文献1

  • 1P. Duvaldestin,M. Demetriou,A. D’Hollander. Pharmacokinetics of pancuronium in man: A linear system[J] 1982,European Journal of Clinical Pharmacology(4):369~372

共引文献6

同被引文献15

  • 1Wood M. Plasma binding and limitation of drug access to site of action.Anesthesiology, 1991,75:721-723.
  • 2Engdahl O, Abrahams M, Bjornsson A, et al. Cerebrospinal fluid concentrations of propofol during anaesthesia in humans. Br J Anaesth,1998,81:957-959.
  • 3Stehling L. Autologous transfusion. In: Miller RD, ed. Anesthesia.5th edn. New York: Churchill livingstone publishers, 2001.1645-1662.
  • 4Wassan KM. Modifications in plasma lipoproteins concentraion and lipid composition regulate the biological activity of hydrophobic drugs. J pharmacol Toxicol, 1996; 36:1-3.
  • 5Altmayer P, Buch U, Buch HP. Propofol binding to human blood proteins. Arzneimittelforschung, 1995,45:1053-1056.
  • 6Hiraoka H, Yamamoto K, Okano N , et al. Changes in drug plasma concentrations of an extensively bound and highly extracted drug,propofol, in response to altered plasma binding. Clin Pharmacol Ther,2004 , 75: 324-330.
  • 7Kleen M, Habler O, Hutter J, et al. Effects of hemodilution on splanchnic perfusion and hepatorenal function. Ⅰ. Splanchnic perfusion. Eur J Med Res, 1997 ,30:413-418.
  • 8Habler O, Kleen M, Hutter J , et al. Effects of hemodilution on splanchnic perfusion and hepatorenal function. Ⅱ. Renal perfusion and hepatorenal function. Eur J Med Res, 1997, 30:419-424.
  • 9Bjorkman S, Wada DR, Berling BM, et al. Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model. J Pharm Sci, 2001,90:1226-1241.
  • 10张欢,许幸,张京范.加速度法和肌力法在肌松监测中的比较[J].中华麻醉学杂志,1997,17(9):523-526. 被引量:8

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部